Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More
S.S.ORGANICS TEVA PHARMA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
S.S.ORGANICS Mar-23 |
TEVA PHARMA Dec-13 |
S.S.ORGANICS/ TEVA PHARMA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 41 | 3,483 | - | |
Low | Rs | 21 | 3,026 | - | |
Sales per share (Unadj.) | Rs | 21.8 | 1,998.8 | - | |
Earnings per share (Unadj.) | Rs | -8.1 | 124.9 | - | |
Cash flow per share (Unadj.) | Rs | -6.7 | 286.4 | - | |
Dividends per share (Unadj.) | Rs | 0 | 109.31 | - | |
Avg Dividend yield | % | 0 | 3.4 | 0.0% | |
Book value per share (Unadj.) | Rs | -32.5 | 2,220.3 | - | |
Shares outstanding (eoy) | m | 14.20 | 848.00 | - | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.4 | 1.6 | 86.6% | |
Avg P/E ratio | x | -3.8 | 26.1 | -14.5% | |
P/CF ratio (eoy) | x | -4.6 | 11.4 | -40.4% | |
Price / Book Value ratio | x | -0.9 | 1.5 | -64.5% | |
Dividend payout | % | 0 | 87.5 | -0.0% | |
Avg Mkt Cap | Rs m | 437 | 2,759,528 | 0.0% | |
No. of employees | `000 | NA | 44.9 | 0.0% | |
Total wages/salary | Rs m | 11 | 0 | - | |
Avg. sales/employee | Rs Th | 0 | 37,712.8 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 2,355.9 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 310 | 1,695,000 | 0.0% | |
Other income | Rs m | 0 | 0 | - | |
Total revenues | Rs m | 310 | 1,695,000 | 0.0% | |
Gross profit | Rs m | -79 | 464,177 | -0.0% | |
Depreciation | Rs m | 21 | 137,008 | 0.0% | |
Interest | Rs m | 15 | 33,293 | 0.0% | |
Profit before tax | Rs m | -114 | 293,876 | -0.0% | |
Minority Interest | Rs m | 0 | 1,335 | 0.0% | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | -192,913 | -0.0% | |
Tax | Rs m | 2 | -3,588 | -0.1% | |
Profit after tax | Rs m | -116 | 105,885 | -0.1% | |
Gross profit margin | % | -25.3 | 27.4 | -92.5% | |
Effective tax rate | % | -1.7 | -1.2 | 142.8% | |
Net profit margin | % | -37.3 | 6.2 | -597.8% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 250 | 1,144,797 | 0.0% | |
Current liabilities | Rs m | 298 | 998,360 | 0.0% | |
Net working cap to sales | % | -15.5 | 8.6 | -179.7% | |
Current ratio | x | 0.8 | 1.1 | 73.1% | |
Inventory Days | Days | 16 | 91 | 17.5% | |
Debtors Days | Days | 119,672,906 | 96 | 124,772,779.8% | |
Net fixed assets | Rs m | 293 | 553,624 | 0.1% | |
Share capital | Rs m | 142 | 4,172 | 3.4% | |
Net worth | Rs m | -462 | 1,882,824 | -0.0% | |
Long term debt | Rs m | 630 | 866,691 | 0.1% | |
Total assets | Rs m | 543 | 3,873,619 | 0.0% | |
Interest coverage | x | -6.6 | 9.8 | -67.6% | |
Debt to equity ratio | x | -1.4 | 0.5 | -296.3% | |
Sales to assets ratio | x | 0.6 | 0.4 | 130.5% | |
Return on assets | % | -18.6 | 3.6 | -517.2% | |
Return on equity | % | 25.0 | 5.6 | 445.4% | |
Return on capital | % | -58.8 | 4.9 | -1,191.6% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | -16 | 270,095 | -0.0% | |
From Investments | Rs m | -96 | -95,706 | 0.1% | |
From Financial Activity | Rs m | 112 | -323,998 | -0.0% | |
Net Cashflow | Rs m | 0 | -149,608 | 0.0% |
Compare S.S.ORGANICS With: MYLAN (US) ADCOCK INGRAM (S. Africa) ACTAVIS (US)
Compare S.S.ORGANICS With: MARKSANS PHARMA. STRIDES PHARMA SCIENCE LASA SUPERGENERICS SHASUN PHARMA WYETH
Asian stocks inched higher on Tuesday as investors awaited a slew of economic data, corporate earnings and the U.S. Federal Reserve's policy meeting.